fda not allowing compounded semaglutide The FDA has removed semaglutide injection products (GLP-1) from the Important Update: Changes to Compounded

Participants saw significant reductions in fasting insulin, improvements in HbA1c levels even in non-diabetic participants, reductions in triglycerides, and improvements in systolic and diastolic blood pressure

The maximum dose of semaglutide used for the treatment of obesity is 2.8 mg/week (0.4 mg/day), whereas the maximum dose for the treatment of T2DM is 1 mg/week

LUPKIN: And another study showed it was also effective at lowering patients' A1C, which is a measure of blood sugar

store reconstituted solution at 4C and use within 72 hours

Neither should hang out in a hot car all day, but can absolutely go into your carry-on bag on a flight